PAE stands for Prostate Artery Embolization, a minimally invasive procedure that shrinks an enlarged prostate by cutting off part of its blood supply. It’s performed by an interventional radiologist rather than a surgeon, and it’s done as an outpatient procedure with no general anesthesia and no surgical incisions. PAE treats the urinary symptoms caused by benign prostatic hyperplasia (BPH), the noncancerous prostate growth that affects most men as they age.
How PAE Works
During a PAE, a radiologist inserts a thin catheter through a small puncture in the wrist or groin and threads it through the arteries until it reaches the blood vessels feeding the prostate. Tiny round particles called microspheres are then injected through the catheter into those vessels, blocking blood flow to the enlarged tissue. Without its blood supply, the overgrown prostate tissue dies off and the gland gradually shrinks. This reduction in size relieves the squeeze on the urethra that causes problems like frequent urination, weak stream, nighttime bathroom trips, and difficulty emptying the bladder.
The procedure targets the transition zone of the prostate, where most of the problematic growth occurs. By inducing tissue death specifically in that zone, PAE also reduces the activity of receptors that contribute to muscle tightness in the prostate, addressing both the physical bulk and the muscular tension that obstruct urine flow. Symptom improvement typically begins within days, though the full effect develops over weeks to months as the prostate continues to shrink.
How Well It Works
Studies show meaningful and lasting symptom relief after PAE. In patients with severe BPH symptoms, standardized symptom scores dropped by about 39% at one month and nearly 68% at three months. At the two-year mark, patients still maintained roughly a 65% reduction in symptoms compared to their pre-procedure baseline, suggesting durable results.
Prostate volume also decreases significantly. Ultrasound measurements at three months showed an average 50% reduction in prostate size, while MRI-based measurements showed a more conservative 16% reduction. The difference reflects the way each imaging method captures the changes, but both confirm that the gland physically shrinks after the procedure.
The American Urological Association currently lists PAE as a conditional recommendation for treating BPH symptoms, meaning it’s considered a reasonable option but with a lower level of evidence than more established procedures. It should be performed by clinicians specifically trained in the technique.
Who Is a Good Candidate
PAE is generally best suited for men whose prostates are larger than 80 grams, as bigger glands tend to respond more favorably. When the prostate is smaller than 40 grams, the results are less predictable, and patients should weigh that uncertainty before choosing the procedure. Men with prostates in the 50 to 80 gram range fall somewhere in between.
The procedure is a strong option for men who haven’t gotten enough relief from medications like alpha blockers or 5-alpha reductase inhibitors. It’s also viable for men who have already tried other procedures, such as transurethral surgery, without success. Studies have shown positive outcomes in patients who underwent PAE after a previous surgical treatment failed.
Recovery After the Procedure
Because PAE is an outpatient procedure, you go home the same day. Most people can return to light daily activities the next day. For the first few days, you should avoid heavy lifting, vigorous exercise, and other strenuous activity.
About one in four patients experiences what’s called post-embolization syndrome in the days following the procedure. This can include burning or discomfort during urination (affecting roughly 22% of patients), pelvic or rectal pain (about 20%), temporary worsening of urinary symptoms (about 33%), and occasionally low-grade fever (around 7%). These symptoms are a normal response to the tissue dying off inside the prostate and typically resolve on their own within a few days.
How PAE Compares to Surgery
The most common surgical alternative is TURP (transurethral resection of the prostate), which removes prostate tissue through the urethra. A large study comparing the two found that PAE patients were discharged from the hospital about 2.6 days earlier than TURP patients. PAE also carried a lower rate of urinary retention afterward: 3.2% compared to 7.1% with TURP. Blood transfusion rates were similar between the two, at about 1.4% for PAE and 1.8% for TURP.
The tradeoff is that TURP has a longer track record and stronger evidence behind it, and it may produce greater improvement in urinary flow rates. PAE offers a less invasive alternative with a faster recovery, which matters for men who want to avoid surgery or who have health conditions that make surgery riskier.
Effects on Sexual Function
One of the most common concerns about any prostate procedure is the impact on sexual function, particularly ejaculation. PAE does carry a risk of ejaculatory changes, but the pattern differs from surgery. After TURP, about 52% of men experience complete loss of ejaculation (where semen redirects into the bladder). After PAE, complete loss of ejaculation occurs in about 16% of cases.
However, PAE causes diminished ejaculation, a noticeable reduction in volume, in roughly 40% of patients. When all ejaculatory changes are combined, about 56% of men undergoing PAE experience some change. This is an important detail that often gets underemphasized: while PAE preserves normal ejaculation more often than surgery, it still affects ejaculatory function in more than half of patients. The changes appear to result from tissue breakdown in structures involved in ejaculation as the prostate shrinks.
Rare but Serious Risks
Severe complications from PAE are uncommon. The most notable rare risk is non-target embolization, where microspheres accidentally travel to blood vessels supplying nearby organs like the bladder or rectum instead of just the prostate. This can cause tissue damage in those areas. Post-procedure sepsis (serious infection) occurred in only 0.3% of patients in a large comparative study, and intensive care admission was needed in 0.7% of cases. Overall, PAE has a strong safety profile, with most side effects being temporary and self-limiting.